G193-0527 Screening compound: N-{3-[1-(2-bromophenyl)-5-methyl-1H-1,2,3-triazol-4-yl]-1,2,4-thiadiazol-5-yl}-3-fluorobenzamide

G193-0527 Screening compound: N-{3-[1-(2-bromophenyl)-5-methyl-1H-1,2,3-triazol-4-yl]-1,2,4-thiadiazol-5-yl}-3-fluorobenzamide
G193-0527 Screening compound: N-{3-[1-(2-bromophenyl)-5-methyl-1H-1,2,3-triazol-4-yl]-1,2,4-thiadiazol-5-yl}-3-fluorobenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G193-0527
N-{3-[1-(2-bromophenyl)-5-methyl-1H-1,2,3-triazol-4-yl]-1,2,4-thiadiazol-5-yl}-3-fluorobenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G193-0527

Molecular Formula

C18H12BrFN6OS (C18 H12 BrFN6 OS)

Compound Name

N-{3-[1-(2-bromophenyl)-5-methyl-1H-1,2,3-triazol-4-yl]-1,2,4-thiadiazol-5-yl}-3-fluorobenzamide

IUPAC name

N-{3-[1-(2-bromophenyl)-5-methyl-1H-123-triazol-4-yl]-124-thiadiazol-5-yl}-3-fluorobenzamide

SMILES

Cc1c(-c2nsc(NC(c3cc(F)ccc3)=O)n2)nnn1-c(cccc1)c1Br

InChI

InChI=1S/C18H12BrFN6OS/c1-10-15(23-25-26(10)14-8-3-2-7-13(14)19)16-21-18(28-24-16)22-17(27)11-5-4-6-12(20)9-11/h2-9H,1H3,(H,21,22,24,27)

InChI Key

VNJYTEAJFBCIKW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14983355

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

459.3

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.177

Distribution Coefficient, logD

4.145

Water Solubility, LogSw

-4.34

Polar Surface Area

70.459

Acid Dissociation Constant (pKa)

8.52

Base Dissociation Constant (pKb)

2.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

5.60

G193-0527 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G193-0527 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G193-0527?
Check Price and Availability of G193-0527, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G193-0527 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G193-0527
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G193-0527
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G193-0527 available by request